The cancellation plays into fears among scientists who worry that Robert F. Kennedy Jr. will use his position as health ...
Despite being the seemingly powerful, very public face of the Department of Government Efficiency (DOGE), with the full ...
Virax Biolabs Group Limited (NASDAQ:VRAX) said it supports the U.S. Department of Health and Human Services’ focus on vaccine efficacy transparency, emphasizing the need for accessible information to ...
Keep up with the latest moves made in health policy under President Donald Trump's second administration. This timeline will ...
Secretary, Measles-dismisser, nepo-baby, bear cub-dumper, and vaccine skeptic, Robert F. Kennedy, Jr., was one of the ...
Kennedy’s first week at HHS included dismissing the workforce, vaccine advisers and some longtime health priorities.
6don MSN
Dynavax reports record HEPLISAV-B revenue, 26% growth in 2024, and strong 2025 guidance. Insights on shingles vaccine progress & market expansion.
4don MSN
“The comment that [Kennedy] made about the vaccine schedule, it’s basically scientific racism, which has been debunked,” Dr.
Dynavax Technologies Corporation ( NASDAQ: DVAX) Q4 2024 Earnings Conference Call February 20, 2025 4:30 PM ET Paul Cox - Vice President, Investor Relations & Corporate Communications Ryan Spencer - ...
Portuguese biotechnology company Immunethep is receiving $2 million from CARB-X to develop a conjugate peptide-based vaccine ...
ACIP holds full-committee public meetings at least three times a year to review evidence on vaccines and vote on new ...
To read this article for FREE, please sign in to your account or sign up for a free account.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results